Please login to the form below

Not currently logged in
Email:
Password:

ProStrakan takeover moves a step closer

Japanese conglomerate Kyowa Hakko Kirin has bought one share in ProStrakan, taking it a step closer to completing a takeover

Kyowa Hakko Kirin (KHK), the Japanese conglomerate, has bought one share in the Scottish specialist pharmaceuticals company ProStrakan, taking it a step closer to completing a takeover.

Tokyo-based KHK is aiming to buy ProStrakan in a bid to grow its oncology drug business outside of Japan. However, under takeover rules, it must own at least one share to complete the "scheme of arrangement" and transfer the ownership of the company.

ProStrakan, which has its headquarters in Galashiels and employs about 70 of its 300 staff in Scotland, has a number of drugs in key global markets including Sancuso, a novel skin patch for the prevention of chemotherapy-induced nausea and vomiting, and cancer pain treatment Abstral (fentanyl). 

ProStrakan's board has supported KHK's £292m approach unanimously.

31st March 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics